Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer

The number of older patients with cancer is increasing as a result of the ageing of Western societies. Immune checkpoint inhibitors have improved cancer treatment and are associated with lower rates of treatment-related toxicity compared with chemotherapy in the general population. Nonetheless, immu...

Descripción completa

Detalles Bibliográficos
Autores principales: van Holstein, Yara, Kapiteijn, Ellen, Bastiaannet, Esther, van den Bos, Frederiek, Portielje, Johanneke, de Glas, Nienke A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764930/
https://www.ncbi.nlm.nih.gov/pubmed/31317421
http://dx.doi.org/10.1007/s40266-019-00697-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764930/
https://www.ncbi.nlm.nih.gov/pubmed/31317421
http://dx.doi.org/10.1007/s40266-019-00697-2

Ejemplares similares